Health and Life Sciences: research integrity under the microscope

Join us as our panel explores how failures of research integrity arise in life sciences and health settings. We will consider the legal, regulatory and corporate risk exposure that can follow when research, data, clinical trials or approvals are called into question.

Drawing on real case studies, our panellists will examine corporate risk, internal controls and investigative responses, and what organisations can do to identify issues early and manage consequences when integrity breaks down.

Regulatory change is likely in the wind and we'll look at what changes may be coming, so that risks can be managed proactively.

Please feel free to extend this invitation to colleagues where appropriate.

Panel

Glenn Sung

Dennis Feeney -  Founder & Director, Venture Technology Group

Michael Cossetto - Corporate & Commercial Partner, Bartier Perry

Details

Thursday 28 May 2026

4.00pm: Registration 

4.15pm: Panel session / livestream commences 

5.15pm: Networking & refreshments

Cost

Free of charge

RSVP

For in-person: by 21 May 

For livestream: by 26 May